Maxim's Strong Incentive..., page-25

Let's say tt-034 early results underwhelm and management state they need
the lab to go re-tweak the design for another 18months, and a week later (after the remaining pillows have been thrown out the cot)
Calimmune report very encouraging HIV trial results.

There's another avenue to our proof of concept for the tech, and likely enough support to fund the re-tweaking of tt-034 and line up HBV for a red hot own it outright curative shot.